Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6332856

COc1ccc(-c2sc(-c3ccc(SC(C)(C)C(=O)O)cc3)nc2C(=O)Nc2ccc(N3CCOCC3)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 1/20 0.43
▸ MAPT P10636 6/20 0.43
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ HCRTR1 O43613 1/20 0.42
▸ APP P05067 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ MAPKAPK2 P49137 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ BTK Q06187 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PPARA Q07869 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ LRRK2 Q5S007 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6327439 0.92 NPC1 (0.46) DGAT1MAPTMEN1KMT2AKDM4E
SCHEMBL6332860 0.91 MAPT (0.43) DGAT1MAPTMEN1KMT2AHCRTR1
Trifluoroacetic Acid SCHEMBL6328364 0.91 DGAT1 (0.44) DGAT1MAPTNPC1RAB9AMAPKAPK2
SCHEMBL6326588 0.90 DGAT1 (0.49) DGAT1MAPTMEN1KMT2AHCRTR1
SCHEMBL6330961 0.87 STAT3 (0.47) MAPTMEN1KMT2AKDM4ENPC1
SCHEMBL6327984 0.85 PPARA (0.54) MAPTMEN1KMT2APPARA
SCHEMBL6326381 0.85 TP53 (0.45) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL6327314 0.84 TP53 (0.47) MAPTMEN1KMT2AKDM4ENPC1
SCHEMBL6327445 0.84 MAPT (0.44) DGAT1MAPTMEN1KMT2ANPC1
SCHEMBL5727205 0.83 DGAT1 (0.46) DGAT1MAPTMEN1KMT2AHCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION 2005-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity GPR119, EGLN3, PC DGAT1 386/4885MAPT 3022/4885MEN1 3157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback